Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANAB Anaptysbio Inc

盘前交易 08-26 05:49:53 EDT

37.75

+0.46

+1.23%

最高38.05	最低36.72	成交量25.21万
今开37.51	昨收37.29	日振幅3.58%
总市值11.40亿	流通市值7.44亿	总股本3,020万
成交额949.63万	换手率1.28%	流通股本1,971万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANAB","market":"US","secType":"STK","nameCN":"Anaptysbio Inc","latestPrice":37.75,"timestamp":1724443200000,"preClose":37.29,"halted":0,"volume":252099,"delay":0,"floatShares":19705185,"shares":30199814,"eps":-6.342959,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.46,"latestTime":"08-26 05:49:53 EDT","open":37.51,"high":38.05,"low":36.715,"amount":9496311.180624,"amplitude":0.0358,"askPrice":42.11,"askSize":100,"bidPrice":15.1,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-6.342959,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724679000000},"adr":0,"listingDate":1485406800000,"adjPreClose":37.75,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":37.75,"preClose":37.75,"latestTime":"19:18 EDT","volume":38968,"amount":1471042,"timestamp":1724455132513},"volumeRatio":0.7064584739532453,"impliedVol":0.5775,"impliedVolPercentile":0.296},"requestUrl":"/m/hq/s/ANAB/tweets","defaultTab":"tweets","newsList":[{"id":"2460007863","title":"Anaptysbio, Inc.盘中异动 股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460007863","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460007863?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:49","pubTimestamp":1724161763,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时49分，Anaptysbio, Inc.股票出现异动，股价大幅下挫5.43%。截至发稿，该股报34.47美元/股，成交量1.1596万股，换手率0.04%，振幅5.41%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃，换手率分别为2104.14%、635.43%、230.35%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、Biomotion Sciences C/Wts Exp 15/08/2029 、泰坦制药，振幅分别为155.95%、78.89%、57.57%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820214923971994e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820214923971994e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2460065607","title":"Anaptysbio, Inc.盘中异动 股价大涨5.13%报35.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460065607","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460065607?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:11","pubTimestamp":1724094717,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时11分，Anaptysbio, Inc.股票出现异动，股价急速拉升5.13%。截至发稿，该股报35.75美元/股，成交量22.5382万股，换手率0.75%，振幅7.28%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为9256.88%、3855.80%、1306.77%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为438.26%、220.18%、198.02%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003115898e3569a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003115898e3569a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4539","BK4139"],"gpt_icon":1},{"id":"2460241799","title":"Anaptysbio, Inc.盘中异动 大幅拉升5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241799","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241799?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:05","pubTimestamp":1723824325,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日00时05分，Anaptysbio, Inc.股票出现异动，股价快速上涨5.70%。截至发稿，该股报34.30美元/股，成交量12.5389万股，换手率0.42%，振幅5.70%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Geovax Labs, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为7203.62%、1905.65%、894.94%，振幅较大的相关个股有Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Geovax Labs, Inc.，振幅分别为162.29%、111.11%、62.68%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081700052597198fbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081700052597198fbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","BK4007","RA","ANAB","BK4139"],"gpt_icon":1},{"id":"2459865922","title":"美国研究综述-Allstate, bluebird bio , Vicinity Motor","url":"https://stock-news.laohu8.com/highlight/detail?id=2459865922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459865922?lang=zh_cn&edition=full","pubTime":"2024-08-16 05:59","pubTimestamp":1723759186,"startTime":"0","endTime":"0","summary":"* Vicinity Motor Corp   ：Alliance Global Partners将其评级从买入下调至持有 以下是路透周四报导的美国公司研究报告摘要。* Cardlytics Inc   ：美国银行全球研究将目标价从4美元下调至3.5美元  * Celcuity Inc   ：杰富瑞将目标价从27美元上调至28美元 * Celcuity Inc   ：Stifel将目标价从40美元下调至39美元 * Century Therapeutics Inc   ：H.C. Wainwright将目标价从11美元下调至9美元 * Chord Energy Corp   ：Piper Sandler 将目标价从 234 美元下调至 206 美元 * Cineve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CIVI","ALL","CPT","EU","LU2326559502.SGD","BE","IPSC","TKNO","LU0205193047.USD","ANAB","CDLX","APA","CNX","LITE","BKKT","AJG","CAH","ABOS","VEV","OZK","AFG","BLFS","CHRD","ASH","CNVS","T","AVB","LU1366192091.USD","BSM","BILL","BRY","DELL","AHR","EAT","BK4515","CLF","LU","AEIS","LU0289739343.SGD","ARAY","CELC","ASTS","AMT","ADSK","BRO","LU0203345920.USD","LU0320765489.SGD","BLUE","GOEV","AKYA"],"gpt_icon":1},{"id":"2459473919","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459473919","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459473919?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:47","pubTimestamp":1723729651,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时47分，Anaptysbio, Inc.股票出现异动，股价快速跳水5.14%。截至发稿，该股报32.87美元/股，成交量4.4206万股，换手率0.16%，振幅6.98%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Scisparc Ltd.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为4245.55%、1714.69%、369.85%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为103.98%、58.54%、50.00%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081521473198e35094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081521473198e35094&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CING","ANAB","RA","BK4007"],"gpt_icon":0},{"id":"2459829172","title":"Anaptysbio, Inc.股价上涨10.01% 市值涨1.01亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459829172","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459829172?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:31","pubTimestamp":1723642276,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时31分，Anaptysbio, Inc.股票出现波动，股价急速上涨10.01%。截至发稿，该股报36.67美元/股，成交量5.0041万股，换手率0.18%，振幅1.68%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Genprex, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为48.99%、42.62%、21.48%，振幅较大的相关个股有Acelyrin, Inc.、Cadrenal Therapeutics, Inc.、Genprex, Inc.，振幅分别为9.24%、8.88%、8.21%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213116959884ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213116959884ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2458682326","title":"Anaptysbio, Inc.2024财年第二财季实现净利润-46.66百万美元，同比减少17.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458682326","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458682326?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:19","pubTimestamp":1723306793,"startTime":"0","endTime":"0","summary":"8月11日，Anaptysbio, Inc.公布财报，公告显示公司2024财年第二财季净利润为-46.66百万美元，同比减少17.09%；其中营业收入为10.97百万美元，同比增加217.05%，每股基本收益为-1.71美元。从资产负债表来看，Anaptysbio, Inc.总负债4.17亿美元，其中短期债务1.85百万美元，资产负债比为1.03，流动比率为0.10。机构评级：截至2024年8月11日，当前有10家机构对Anaptysbio, Inc.目标价做出预测，其中目标均价为56.40美元，其中最低目标价为20.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001959958e7548&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001959958e7548&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB"],"gpt_icon":0},{"id":"2458373347","title":"Anaptysbio, Inc.盘中异动 股价大涨5.04%报33.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458373347","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458373347?lang=zh_cn&edition=full","pubTime":"2024-08-09 01:14","pubTimestamp":1723137244,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日01时14分，Anaptysbio, Inc.股票出现波动，股价急速拉升5.04%。截至发稿，该股报33.13美元/股，成交量3.9905万股，换手率0.15%，振幅5.49%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为3.27%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Aldeyra Therapeutics, Inc.、Senti Biosciences, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为418.69%、294.93%、188.26%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为128.24%、54.41%、45.58%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408090114049682539c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408090114049682539c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2457821758","title":"美国研究综述-安进、Atkore、MoneyLion","url":"https://stock-news.laohu8.com/highlight/detail?id=2457821758","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457821758?lang=zh_cn&edition=full","pubTime":"2024-08-08 00:34","pubTimestamp":1723048497,"startTime":"0","endTime":"0","summary":"    路透8月7日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括安进公司、Atkore公司和MoneyLion公司。要闻 * 安进公司  ：加拿大皇家银行将目标价从332美元上调至362美元 * Atkore Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。* MoneyLion   ：Needham将目标价从100美元下调至70美元 * Progyny Inc   ：BTIG将其评级从 \"买入 \"下调至 \"中性\"。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABL","AVNT","IE00B19Z4B17.USD","AMWL","ANAB","AZPN","AMGN","ARCT","ADTN","AZTA","AHCO","BK4548","ADUS","AXON","CAR","ASH","LU1023059063.AUD","AIRG","IE00BJT1NW94.SGD","AGL","BK4109","ASPI","ARMK","BBWI","BK4006","IE0031619046.USD","LU0122379950.USD","ALAB","AVB","LU1989773731.SGD","AMH","BEAM","GOLF","AESI","BWIN","AEE","AEP","ALGT","ACM","BAX","ATKR","ACAD","ATI","CELH","LU0289739699.SGD","IE00B7SZLL34.SGD","LU1057294990.SGD","ACA","IE00B3S45H60.SGD","ALIT"],"gpt_icon":1},{"id":"2457882895","title":"美国研究综述-安进、Atkore、Moneylion","url":"https://stock-news.laohu8.com/highlight/detail?id=2457882895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457882895?lang=zh_cn&edition=full","pubTime":"2024-08-07 16:03","pubTimestamp":1723017814,"startTime":"0","endTime":"0","summary":"    路透8月7日 - 华尔街证券分析师周三调整了对安进、Atkore 和 Moneylion 等几家美国上市公司的评级和目标价。要闻             * 安进公司  ：加拿大皇家银行将其目标价从332美元上调至362美元             * Atkore Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAT","CRBU","AMH","ADTN","BEAM","CBT","BLMN","H","IE00B775SV38.USD","BK4090","LU0868494708.USD","XAIR","AMWL","CERT","LU1989773731.SGD","AEP","BK4566","BR","AZPN","ARMK","BLDR","ACAD","ATI","AVNT","ALIT","BRBR","CAR","AZTA","BWIN","LU2098885051.SGD","BL","ADUS","BK4149","IE00B7SZL793.SGD","AMGN","ANAB","LUMN","BCC","BK4551","BK4020","BAX","ALAB","ALGT","ATKR","BBWI","IE0002141913.USD","LU1894683348.USD","RDDT","BRKR","BBIO"],"gpt_icon":1},{"id":"2457044026","title":"美国研究综述-Actinium Pharmaceuticals、Albemarle、ArcBest","url":"https://stock-news.laohu8.com/highlight/detail?id=2457044026","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457044026?lang=zh_cn&edition=full","pubTime":"2024-08-06 20:56","pubTimestamp":1722949016,"startTime":"0","endTime":"0","summary":"    路透8月6日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Actinium Pharmaceuticals、Albemarle 和 ArcBest。要点   * Actinium Pharmaceuticals Inc   ：JonesTrading将其交易价格从26美元下调至9美元 * Albemarle   ：Baird将其评级下调至中性，目标价从102美元下调至85美元 * ArcBest Corp   ：Stephens 将目标价从 145 美元下调至 130 美元 * Crispr Therapeutics AG   ：Leerink Partners将目标价从80美元下调至68美元 * Warrior Met Coal Inc   ：杰富瑞将目标价从85美元下调至78美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASPN","AXSM","CDNS","LU1323610961.USD","ALB","BK","AMWL","ETNB","AMRC","LU0648001328.SGD","BMRN","BK4231","BIIB","ARCH","ATIP","APO","AHR","IE00B1XK9C88.USD","IE00BKDWB100.SGD","ALX","BN","ALL","LNT","BKH","CWT","AIG","AN","ANAB","CABO","AQMS","BK4129","BK4519","LU","ALHC","AEE","ARCB","AKYA","CG","BCRX","AES","AEP","LU0354030511.USD","LU1978683503.SGD","CTRE","CBT","ADUS"],"gpt_icon":1},{"id":"2457085032","title":"AnaptysBio Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457085032","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457085032?lang=zh_cn&edition=full","pubTime":"2024-08-06 05:02","pubTimestamp":1722891749,"startTime":"0","endTime":"0","summary":"   * AnaptysBio Inc   报告，截至6月底的季度调整后每股亏损1.71美元，低于去年同期的每股收益1.50美元。11 位分析师对该季度的平均预期是每股亏损 89 美分。华尔街预期为每股亏损 1.73 美元至 11 美分。* AnaptysBio Inc报告的本季度每股收益为亏损1.71美元。* 该公司一季度亏损4666万美元。* AnaptysBio Inc的股价本季度上涨了30.7%，今年迄今为止上涨了52.9%。8月5日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 44.2%。华尔街对 AnaptysBio Inc 的 12 个月目标价中位数为 48.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AnaptysBio Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2457204187","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.04%报31.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457204187","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457204187?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864734,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Anaptysbio, Inc.股票出现异动，股价快速下挫5.04%。截至发稿，该股报31.11美元/股，成交量528股，换手率0.00%，振幅1.18%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Zevra Therapeutics, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为981.63%、35.48%、13.54%，振幅较大的相关个股有Vor Biopharma Inc.、Cue Biopharma, Inc.、Compass Therapeutics, Inc.，振幅分别为13.04%、12.33%、12.19%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080521321598e34c08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080521321598e34c08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2456299161","title":"AnaptysBio Inc   预计每股亏损89美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456299161","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456299161?lang=zh_cn&edition=full","pubTime":"2024-08-03 10:05","pubTimestamp":1722650758,"startTime":"0","endTime":"0","summary":"* LSEG分析师对AnaptysBio公司的平均预期是每股亏损89美分。* 华尔街对 AnaptysBio Inc 的 12 个月目标价中位数为 48.50 美元，高于其上一次收盘价 32.76 美元。8月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AnaptysBio Inc   预计每股亏损89美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB"],"gpt_icon":0},{"id":"2456935281","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.49%报32.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456935281","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456935281?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605488,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分，Anaptysbio, Inc.股票出现异动，股价急速下跌5.49%。截至发稿，该股报32.21美元/股，成交量9544股，换手率0.03%，振幅0.00%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Os Therapies Incorporated涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为213.97%、40.51%、16.51%，振幅较大的相关个股有Nuvation Bio Inc.、Xencor, Inc.、Molecular Partners Ag，振幅分别为9.01%、8.12%、8.00%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213128aefcf830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213128aefcf830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2455896312","title":"Anaptysbio, Inc.盘中异动 急速下跌5.11%报35.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455896312","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455896312?lang=zh_cn&edition=full","pubTime":"2024-07-31 01:00","pubTimestamp":1722358801,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日01时00分，Anaptysbio, Inc.股票出现波动，股价快速下挫5.11%。截至发稿，该股报35.11美元/股，成交量11.6525万股，换手率0.43%，振幅6.91%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Imunon, Inc.、Celularity Inc C/Wts 16/07/2026 、Processa Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为1904.49%、1500.62%、1250.41%，振幅较大的相关个股有Imunon, Inc.、Cns Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.，振幅分别为78.15%、59.59%、55.88%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731010002941fbf96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731010002941fbf96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2454778178","title":"Anaptysbio, Inc.盘中异动 早盘快速上涨5.09%报38.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454778178","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454778178?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:28","pubTimestamp":1721917693,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时28分，Anaptysbio, Inc.股票出现异动，股价大幅拉升5.09%。截至发稿，该股报38.78美元/股，成交量2.3606万股，换手率0.09%，振幅4.39%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Viking Therapeutics, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Azitra Inc较为活跃，换手率分别为2225.78%、432.66%、174.51%，振幅较大的相关个股有Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为117.35%、98.60%、82.05%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407252228139682055b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407252228139682055b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2453792825","title":"美国研究综述-Align Technology、McKesson、Schneider National","url":"https://stock-news.laohu8.com/highlight/detail?id=2453792825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453792825?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:31","pubTimestamp":1721662281,"startTime":"0","endTime":"0","summary":"    路透7月22日 - 华尔街证券分析师周一调整了对 Align Technology、McKesson 和 Schneider National 等几家美国上市公司的评级和目标价。* McKesson Corp   ：瑞银将目标价从630美元上调至670美元              * Schneider National   ：美国银行全球研究将其评级从 \"中性 \"下调至 \"跑输大市\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHLB","ALV","BE","ALGN","BANR","ACM","LU1880398554.USD","APA","OZK","AUGX","ADC","CMA","AVBP","AXSM","ANF","LU0149725797.USD","BHP","ARCB","BKU","TXG","ALX","AXL","AAL","BANF","AEP","AGEN","AXP","LU1244550221.USD","PINE","BGS","LU0476273544.USD","BAC","AN","AMRC","BCBP","LU2242652126.USD","PPG","AA","AMZN","IE0034235188.USD","BCML","BMI","AGCO","BNTC","AMD","BRBR","BK4141","AES","LU","ANAB"],"gpt_icon":0},{"id":"2453928627","title":"Anaptysbio, Inc.盘中异动 早盘急速上涨5.12%报35.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453928627","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453928627?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:18","pubTimestamp":1721661488,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日23时18分，Anaptysbio, Inc.股票出现异动，股价急速上涨5.12%。截至发稿，该股报35.43美元/股，成交量7.5317万股，换手率0.28%，振幅4.33%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Apollomics Inc C/Wts 01/04/2028 、木薯科学涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Mei Pharma, Inc.较为活跃，换手率分别为116.51%、101.71%、56.89%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、木薯科学、Mei Pharma, Inc.，振幅分别为44.07%、33.41%、32.17%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722231808941f9344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722231808941f9344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"2453276823","title":"AnaptysBio(ANAB.US)获HC Wainwright &amp; Co.首次覆盖，给予买入评级, 目标价55.","url":"https://stock-news.laohu8.com/highlight/detail?id=2453276823","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453276823?lang=zh_cn&edition=full","pubTime":"2024-07-22 18:46","pubTimestamp":1721645165,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ANAB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anaptysbio.com","stockEarnings":[{"period":"1week","weight":0.1103},{"period":"1month","weight":0.023},{"period":"3month","weight":0.5788},{"period":"6month","weight":0.4592},{"period":"1year","weight":0.8642},{"period":"ytd","weight":0.7624}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AnaptysBio, Inc.在特拉华成立于2005年11月。该公司是一家为了满足治疗消除炎症和免疫肿瘤的需求，而开发先入级抗体产品。他们开发使用自己的专利-抗体筛选技术平台，其平台目的是复制在体外的候选产品，以抗体产生的自然过程。他们的收入来源是合作研究和开发安排。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.00144},{"month":2,"riseRate":0.875,"avgChangeRate":0.0982},{"month":3,"riseRate":0.25,"avgChangeRate":-0.083331},{"month":4,"riseRate":0.375,"avgChangeRate":0.003799},{"month":5,"riseRate":0.375,"avgChangeRate":-0.031718},{"month":6,"riseRate":0.625,"avgChangeRate":0.007623},{"month":7,"riseRate":0.5,"avgChangeRate":0.019018},{"month":8,"riseRate":0.625,"avgChangeRate":0.038559},{"month":9,"riseRate":0.571429,"avgChangeRate":0.022456},{"month":10,"riseRate":0.714286,"avgChangeRate":0.280813},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.09828},{"month":12,"riseRate":0.714286,"avgChangeRate":0.114651}],"exchange":"NASDAQ","name":"Anaptysbio Inc","nameEN":"Anaptysbio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anaptysbio Inc,ANAB,Anaptysbio Inc股票,Anaptysbio Inc股票老虎,Anaptysbio Inc股票老虎国际,Anaptysbio Inc行情,Anaptysbio Inc股票行情,Anaptysbio Inc股价,Anaptysbio Inc股市,Anaptysbio Inc股票价格,Anaptysbio Inc股票交易,Anaptysbio Inc股票购买,Anaptysbio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}